Related Experiment Video
Updated: Apr 3, 2026
04:32
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
12.7K
COPD patients with ventilator-associated pneumonia: implications for management.
D Koulenti1,2, S Blot3,4, J M Dulhunty2,5
12nd Critical Care Department, Attikon University Hospital, Athens, Greece.
Summary
Chronic obstructive pulmonary disease (COPD) patients do not develop ventilator-associated pneumonia (VAP) more often, but VAP significantly worsens outcomes, increasing mortality and ICU stay. Early VAP in COPD patients shows higher Pseudomonas aeruginosa rates.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Infectious Diseases
Background:
- Limited data exists on chronic obstructive pulmonary disease (COPD) and ventilator-associated pneumonia (VAP) in intensive care units (ICUs).
- Understanding VAP development, etiology, and outcomes in COPD patients is crucial for improving patient care.
Purpose of the Study:
- To investigate if COPD patients have a higher incidence of VAP.
- To compare the microbiological etiology of VAP in COPD versus non-COPD patients.
- To assess the impact of VAP on outcomes, including mortality and length of stay, for COPD patients.
Main Methods:
- Secondary analysis of a prospective, observational study across 27 European ICUs.
- Inclusion of 2082 intubated patients, excluding trauma cases.
- Comparison of VAP rates, causative pathogens, and clinical outcomes between COPD and non-COPD patient groups.
Main Results:
- COPD patients did not show a higher predisposition to VAP development (19.9% vs 19.7%).
- VAP in COPD patients significantly increased ICU mortality (17%, OR 2.28) and prolonged mechanical ventilation (12 days) and ICU stay (>13 days).
- Pseudomonas aeruginosa was more frequent in VAP cases with COPD (29.1% vs 18.7%) and particularly in early-onset VAP (33.3% vs 13.3%).
Conclusions:
- While COPD patients are not more prone to VAP, its occurrence leads to substantially worse outcomes.
- Empirical antibiotic therapy for COPD patients, including those with early-onset VAP, should cover non-fermenting bacteria.
- Targeted VAP management strategies are essential for improving prognosis in ICU patients with COPD.
More Related Videos
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:30Pneumonia I: Introduction
1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
01:30Pneumonia III: Complications and Assessment
1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.5K